No. Arkstone uses in-the-loop supervised machine learning, artificial intelligence, and human oversight to provide decision making tools to providers. OneChoice is classified by the FDA as clinical decision support software (CDSS), intended to help prescribers make informed decisions.
Arkstone is also not a telemedicine service. While some of Arkstone's employees are physicians and are available to answer questions pertaining to how our recommendations are made, they cannot discuss patient details or consult on treatment.
Was this article helpful?
That’s Great!
Thank you for your feedback
Sorry! We couldn't be helpful
Thank you for your feedback
Feedback sent
We appreciate your effort and will try to fix the article